We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 15, 2021

BNT162b2 and mRNA-1273 Vaccines for COVID-19

The New England Journal of Medicine


Additional Info

The New England Journal of Medicine
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
N. Engl. J. Med 2021 Jun 30;[EPub Ahead of Print], MG Thompson, JL Burgess, AL Naleway, H Tyner, SK Yoon, J Meece, LEW Olsho, AJ Caban-Martinez, AL Fowlkes, K Lutrick, HC Groom, K Dunnigan, MJ Odean, K Hegmann, E Stefanski, LJ Edwards, N Schaefer-Solle, L Grant, K Ellingson, JL Kuntz, T Zunie, MS Thiese, L Ivacic, MG Wesley, J Mayo Lamberte, X Sun, ME Smith, AL Phillips, KD Groover, YM Yoo, J Gerald, RT Brown, MK Herring, G Joseph, S Beitel, TC Morrill, J Mak, P Rivers, BP Poe, B Lynch, Y Zhou, J Zhang, A Kelleher, Y Li, M Dickerson, E Hanson, K Guenther, S Tong, A Bateman, E Reisdorf, J Barnes, E Azziz-Baumgartner, DR Hunt, ML Arvay, P Kutty, AM Fry, M Gaglani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading